VOLITIONRX LTD·4

Jan 14, 2:10 PM ET

TERRELL JASON BRADLEY MD 4

4 · VOLITIONRX LTD · Filed Jan 14, 2020

Insider Transaction Report

Form 4
Period: 2020-01-12
TERRELL JASON BRADLEY MD
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2020-01-12$4.79/sh11,364$54,43450,000 total
Footnotes (1)
  • [F1]The reported transaction, consisting of the Issuer's repurchase of shares of common stock from the Reporting Person, was approved by the compensation committee of the Board of Directors (comprised of three "non-employee directors") and, pursuant to Rule 16b-3(e), is exempted from matching for purposes of Section 16(b) of the Exchange Act.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT